ZURIVID Trademark

Trademark Overview

On Thursday, February 11, 2016, a trademark application was filed for ZURIVID with the United States Patent and Trademark Office. The USPTO has given the ZURIVID trademark a serial number of 86905539. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2019. This trademark is owned by Wellstat Therapeutics Corporation. The ZURIVID trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease, neurodegenerative disease and antidotes
zurivid

General Information

Serial Number86905539
Word MarkZURIVID
Filing DateThursday, February 11, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 5, 2016

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease, neurodegenerative disease and antidotes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 18, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameWellstat Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameWellstat Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Monday, September 30, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 30, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, January 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 17, 2019EXTENSION 5 GRANTED
Wednesday, January 9, 2019EXTENSION 5 FILED
Thursday, January 17, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 9, 2019TEAS EXTENSION RECEIVED
Wednesday, July 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 2, 2018EXTENSION 4 GRANTED
Monday, July 2, 2018EXTENSION 4 FILED
Monday, July 2, 2018TEAS EXTENSION RECEIVED
Tuesday, June 12, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 12, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 31, 2018EXTENSION 3 GRANTED
Wednesday, January 31, 2018EXTENSION 3 FILED
Wednesday, January 31, 2018TEAS EXTENSION RECEIVED
Wednesday, August 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 21, 2017EXTENSION 2 GRANTED
Monday, August 21, 2017EXTENSION 2 FILED
Monday, August 21, 2017TEAS EXTENSION RECEIVED
Saturday, February 25, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2017EXTENSION 1 GRANTED
Thursday, February 23, 2017EXTENSION 1 FILED
Thursday, February 23, 2017TEAS EXTENSION RECEIVED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, May 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 26, 2016ASSIGNED TO EXAMINER
Thursday, February 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 15, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

zurivid disease neurodegenerative antidotes mitochondrial oncology products preparations fields pharmaceutical